INDIANAPOLIS, July 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2024 financial results on Aug. 8, 2024. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at . A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news or follow us on Facebook, Instagram and LinkedIn. F-LLY
Refer to: | Jordan Bishop; jordan.bishop@lilly.com; 317-374-1878 (Media) |
| Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors) |
![Cision big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240725/0-1ece82c2b6986195a12feedcc7daa6ba-1-e46d2cebef7453053c512ac040db7ec7.png/big)
View original content to download multimedia:
SOURCE Eli Lilly and Company
Eli Lilly and Company (纽交所:LLY)将于2024年8月8日公布2024年第二季度财报。届时,公司将召开投资者电话会议并向媒体披露更多财务信息。
电话会议将于东部时间上午10点开始。投资者、媒体和公众都可以通过Eli Lilly and Company官网上发布的链接实时访问电话会议的网络直播。电话会议结束后,公司还将在官网上提供回放服务。
关于Lilly
Lilly是一家利用生物技术,推动科技创新实现人类疾病治愈的药品公司,致力于让世界各地的人们享用更好的生活。我们拥有近150年的生物技术研究和发现历史,现已向全球5100万人提供治疗药品。我们的科学家借助生物技术、化学与基因药物的力量,积极推进各项创新。我们正在应对一些全球性的重大健康挑战,重新定义糖尿病护理,治疗和控制肥胖症最具破坏性的长期后果,致力于抗击阿尔茨海默病,为一些难以治疗的免疫系统疾病提供解决方案,并将最难治疗的癌症转化为可控制的疾病。每向更健康的世界迈进一步,我们的动力都源于一个信念:为数百万人提供更好的生活。我们还通过反映世界多元化的创新性临床试验以及努力使我们的药品易于获取和负担得起来实现了这一信念。要了解更多信息,请访问Lilly.com和Lilly.com/news或关注我们的Facebook、Instagram和LinkedIn。F-LLY
乔丹·毕晓普; jordan.bishop@lilly.com | 乔丹·毕夏普;jordan.bishop@lilly.com;317-374-1878(媒体) |
| 乔·弗莱彻;jfletcher@lilly.com;317-296-2884(投资者) |
![Cision 大](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240725/0-1ece82c2b6986195a12feedcc7daa6ba-1-e46d2cebef7453053c512ac040db7ec7.png/big)
查看下载多媒体原始内容:
资讯 Eli Lilly and Company